ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Drug Discovery

Metagenomi raises $65 million for new CRISPR systems

by Ryan Cross
November 21, 2020 | APPEARED IN VOLUME 98, ISSUE 45

 

Metagenomi, a start-up quietly founded by University of California, Berkeley, scientists in 2018, has raised $65 million in series A financing. The name refers to the growing field of metagenomics—the study of genetic material obtained from environmental samples and a method for studying microbes that can’t be cultured in the lab. Metagenomi uses algorithms to scan the genomes of thousands of microbes to find proteins that can be turned into new CRISPR gene-editing systems. It is targeting drugs for cancer and rare genetic diseases.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment